Exploring trends and transactions in the dietary supplements space; parsing Vistria‘s debut multi-asset CV transaction and EQT’s entry into the secondaries market with its acquisition of Coller ...

MS Pharma Group, a leading regional pharmaceutical company in the MENA region, has signed a strategic partnership agreement with Hetero Group, a global pharmaceutical company, to localize five ...

BioArctic AB's (publ) (STO: BIOA B) partner Eisai announced today that the supplemental Biologics License Application (sBLA) ...

MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to the ...

The Handmaid’s Tale cast is booked and busy with new projects — including the Testaments spinoff — after the Hulu series came to a shocking end. The Handmaid’s Tale universe was brought to life when ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Artisan Mid Cap Fund outperformed its benchmark in Q4 2025 despite a modest absolute decline. Read the full Q4 commentary for ...

The Artisan Mid Cap Fund outpaced the Russell Midcap Growth Index in Q4 2025 despite a modest negative absolute return. Read ...

LILONGWE-(MaraviPost)-Malawi Police Service in Kasungu have arrested three men for allegedly being found in possession of counterfeit US dollars. Kasungu Police Public Relations Officer (PRO), Joseph ...

This month: cuffless BP issues in practice, women and lifetime CVD risk, targeting kids for early education, and more.